Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | AKT1 | P31749 | 2/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.43 |
| ▸ | CDC25A | P30304 | 1/20 | 0.43 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8641241 | 0.84 | LMNA (0.44) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL3395881 | 0.83 | SRC (0.38) | LMNACYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL1263901 | 0.83 | LMNA (0.43) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL1085919 | 0.81 | HTT (0.44) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL2912361 | 0.80 | NPC1 (0.48) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL8154893 | 0.79 | LMNA (0.47) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL2825992 | 0.77 | LMNA (0.45) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL30681640 | 0.75 | ALDH1A1 (0.44) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL12844852 | 0.73 | CYP1A2 (0.61) | LMNAESR1KCNH2CYP1A2CYP2C9 | |
| SCHEMBL19244145 | 0.72 | LMNA (0.46) | LMNAAKT1ESR1ADORA3CDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119997981-A | Particulate compositions comprising peptides and uses thereof | 塔西亚制药公司 | 2025-05-13 | — | — | CN | disclosed |
| US-20210238311-A1 | ANTIBODIES AGAINST PHOSPHORYLCHOLINE | ATHERA BIOTECHNOLOGIES AB (SE) | 2021-08-05 | — | — | US | disclosed |
| US-20210230310-A1 | ANTIBODIES BINDING TO PHOSPHORYLCHOLINE (PC) AND/OR PC CONJUGATES | ATHERA BIOTECHNOLOGIES AB (SE) | 2021-07-29 | — | — | US | disclosed |
| EP-2742068-B1 | NEW ANTIBODIES AGAINST PHOSPHORYLCHOLINE | ATHERA BIOTECHNOLOGIES AB (SE) | 2019-04-03 | — | — | EP | disclosed |
| US-20180086848-A1 | ANTIBODIES AGAINST PHOSPHORYLCHOLINE | ATHERA BIOTECHNOLOGIES AB (SE) | 2018-03-29 | — | — | US | disclosed |
| US-20180086847-A1 | ANTIBODIES BINDING TO PHOSPHORYLCHOLINE (PC) AND/OR PC CONJUGATES | ATHERA BIOTECHNOLOGIES AB (SE) | 2018-03-29 | — | — | US | disclosed |
| US-9803028-B2 | Antibodies against phosphorylcholine | ATHERA BIOTECHNOLOGIES AB (SE) | 2017-10-31 | — | — | US | disclosed |
| US-9796786-B2 | Antibodies binding to phosphorylcholine (PC) and/or PC conjugates | ATHERA BIOTECHNOLOGIES AB (SE) | 2017-10-24 | — | — | US | disclosed |
| US-20140193413-A1 | ANTIBODIES BINDING TO PHOSPHORYLCHOLINE (PC) AND/OR PC CONJUGATES | DYAX CORP. (US) | 2014-07-10 | — | — | US | disclosed |
| US-20140178410-A1 | ANTIBODIES AGAINST PHOSPHORYLCHOLINE | DYAX CORP. (US) | 2014-06-26 | — | — | US | disclosed |
| EP-2742068-A1 | NEW ANTIBODIES AGAINST PHOSPHORYLCHOLINE | Athera Biotechnologies AB (SE) | 2014-06-18 | — | — | EP | disclosed |
| EP-2741770-A1 | ANTIBODIES BINDING TO PHOSPHORYLCHOLINE (PC) AND/OR PC CONJUGATES | Athera Biotechnologies AB (SE) | 2014-06-18 | — | — | EP | disclosed |
| WO-2013022968-A1 | ANTIBODIES BINDING TO PHOSPHORYLCHOLINE (PC) AND/OR PC CONJUGATES | ATHERA BIOTECHNOLOGIES AB (SE) | 2013-02-14 | — | — | WO | disclosed |
| WO-2013020995-A1 | NEW ANTIBODIES AGAINST PHOSPHORYLCHOLINE | ATHERA BIOTECHNOLOGIES AB (SE) | 2013-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210230310-A1 | ANTIBODIES BINDING TO PHOSPHORYLCHOLINE (PC) AND/OR PC CONJUGATES | IGLV6-57, VSIG8, IGSF11 | LMNA 3639/4885AKT1 3142/4885ESR1 3488/4885 |
| US-20180086847-A1 | ANTIBODIES BINDING TO PHOSPHORYLCHOLINE (PC) AND/OR PC CONJUGATES | IGLV6-57, VSIG8, IGSF11 | LMNA 3639/4885AKT1 3142/4885ESR1 3488/4885 |
| US-20140193413-A1 | ANTIBODIES BINDING TO PHOSPHORYLCHOLINE (PC) AND/OR PC CONJUGATES | IGLV6-57, VSIG8, IGSF11 | LMNA 3909/4885AKT1 3330/4885ESR1 3906/4885 |
| US-20210238311-A1 | ANTIBODIES AGAINST PHOSPHORYLCHOLINE | IGLV6-57, IGSF11, VSIG8 | LMNA 3791/4885AKT1 3386/4885ESR1 3816/4885 |
| US-20140178410-A1 | ANTIBODIES AGAINST PHOSPHORYLCHOLINE | IGLV6-57, IGSF11, VSIG8 | LMNA 3791/4885AKT1 3386/4885ESR1 3816/4885 |
| US-20180086848-A1 | ANTIBODIES AGAINST PHOSPHORYLCHOLINE | IGLV6-57, IGSF11, VSIG8 | LMNA 3791/4885AKT1 3386/4885ESR1 3816/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.